Biosintesis

Biological Studies

PRECLINICAL BIOTECHNOLOGY

The purpose of the preclinical phase (non-clinical) of a product, chemical substance or biomaterial is the establishment of its safety in human, veterinary or environmental use. The toxic potential, the pharmacological properties, pharmacokinetics, dose variations, stability, therapeutic efficacy (pharmacological research), adverse effects (toxicological research) and metabolism (pharmacokinetic research) of a product or substance are studied by Biosintesis during the evaluation process.

 

Our job is to find reliable solutions for preclinical studies.

 

PRECLINICAL BIOLOGICAL TRIALS PERFORMED BY BIOSINTESIS

 

 

  • Efficacy evaluation
  • Toxicological evaluation (safety)
  • Support to  programs of research and development
  • Patenting
  • Quality control
  • Records provided by national and international health regulations